MediciNova Announces First Advanced ALS Patient Using Non-Invasive Ventilation Support Enrolled in Phase 2 Clinical Trial of MN-166

By: via Benzinga
MediciNova, Inc. (NASDAQ: MNOV) today announced that the first advanced ALS patient, using non-invasive ventilation (NIV), has enrolled ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.